Short Bowel Syndrome Patients Benefit from Medication to Enhance Absorption, According to Option Care Study

DEERFIELD, Ill. – Sixty-three percent of patients with short bowel syndrome who took teduglutide (TED) to enhance gastrointestinal absorption were able to reduce their parenteral support (PS), according to a study1 presented by Option Care Enterprise, Inc. this weekend at the 2015 American College of Gastroenterology (ACG) Annual Scientific Meeting in Honolulu.

Option Care, one of the nation’s largest infusion services companies, presentedTeduglutide Treatment in Adult Patients with Short Bowel Syndrome (SBS): Initial Clinical Experience of Management through a Specialized Infusion Pharmacy (SIP) Service.” The poster highlights results of data analysis of the clinical management of teduglutide therapy provided by a specialized infusion pharmacy in the home-care setting.

In the study of 52 patients with short bowel syndrome who received TED, 63 percent attained a 20 percent to 100 percent reduction in PS volume at weeks 20 and 24. TED treatment resulted in additional days off of PS per week for many patients, with 23 (44 percent) gaining one day or more per week off, 20 (38.5 percent) gaining two days or more off and 15 (28.8 percent) gaining three or more days off PS. Nine patients (17.3 percent) gained complete PS independence.1

“These observations confirm the ability of TED to reduce PS dependence in patients with short bowel syndrome treated in a non-trial setting with close monitoring by a multidisciplinary team,” said Kendra Curry, PharmD, Corporate Director, Specialty Infusion Programs with Option Care.

About the American College of Gastroenterology

Founded in 1932, the American College of Gastroenterology (ACG) is an organization with an international membership of more than 12,500 individuals from 86 countries. The College’s vision is to be the pre-eminent professional organization that champions the evolving needs of clinicians in the delivery of high quality, evidence-based, and compassionate health care to gastroenterology patients. The mission of the College is to advance world-class care for patients with gastrointestinal disorders through excellence, innovation and advocacy in the areas of scientific investigation, education, prevention and treatment. www.gi.org

About Option Care

Option Care, formerly Walgreens Infusion Services Inc., offers clinical care provided by specially trained infusion nurses, pharmacists and dietitians who treat patients with a wide range of acute, chronic and rare conditions. As one of the nation’s largest providers of home and alternate treatment site infusion services, Option Care has 92 infusion pharmacies and 110 alternate treatment sites across the country. Learn more at www.OptionCare.com.

1 Petruccelli K, Youssef N, Li B, Curry K. Teduglutide treatment in adult patients with short bowel syndrome (SBS): initial clinical experience of management through a specialized infusion pharmacy (SIP) service. Poster session presented at: the American College of Gastroenterology’s (ACG) 80th Annual Scientific Meeting; 2015 Oct 16-21; Honolulu, HI.

# # #

Media Contact Information

Option Care
Lauren Kotarski
312-558-1770
LKotarski@pcipr.com